$NKTR·4

NEKTAR THERAPEUTICS · Nov 20, 5:27 PM ET

NEKTAR THERAPEUTICS 4

4 · NEKTAR THERAPEUTICS · Filed Nov 20, 2015

Insider Transaction Report

Form 4
Period: 2015-11-18
WANG SUSAN
Director
Transactions
  • Sale

    Common Stock

    2015-11-19$15.02/sh15,128$227,22320,000 total
  • Exercise/Conversion

    Common Stock

    2015-11-18$8.37/sh+15,000$125,55035,000 total
  • Sale

    Common Stock

    2015-11-18$15.00/sh15,000$225,00020,000 total
  • Exercise/Conversion

    Common Stock

    2015-11-18$5.14/sh+5,372$27,61225,372 total
  • Exercise/Conversion

    Common Stock

    2015-11-19$5.14/sh+15,128$77,75835,128 total
  • Exercise/Conversion

    Common Stock

    2015-11-20$5.14/sh+9,500$48,83029,500 total
  • Exercise/Conversion

    Stock Option

    2015-11-1915,1289,500 total
    Exercise: $5.14From: 2012-09-30Exp: 2019-09-12Common Stock (15,128 underlying)
  • Exercise/Conversion

    Stock Opion

    2015-11-2040,0000 total
    Exercise: $9.24From: 2013-09-30Exp: 2020-09-13Common Stock (40,000 underlying)
  • Sale

    Common Stock

    2015-11-18$15.00/sh5,372$80,58020,000 total
  • Sale

    Common Stock

    2015-11-20$15.02/sh9,500$142,69020,000 total
  • Exercise/Conversion

    Common Stock

    2015-11-20$9.24/sh+40,000$369,60060,000 total
  • Sale

    Common Stock

    2015-11-20$15.02/sh40,000$600,80020,000 total
  • Exercise/Conversion

    Stock Option

    2015-11-1815,0000 total
    Exercise: $8.37From: 2010-09-30Exp: 2017-09-14Common Stock (15,000 underlying)
  • Exercise/Conversion

    Stock Option

    2015-11-185,37224,628 total
    Exercise: $5.14From: 2012-09-30Exp: 2019-09-12Common Stock (5,372 underlying)
  • Exercise/Conversion

    Stock Option

    2015-11-209,5000 total
    Exercise: $5.14From: 2012-09-30Exp: 2019-09-12Common Stock (9,500 underlying)
Footnotes (3)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $15.00 to $15.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  • [F3]This transaction was executed in multiple trades at prices ranging from $15.00 to $15.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION